bioSyntagma Company
bioSyntagma develops molecular fingerprint for diagnosing and discovering disease.
Headquarters:
Phoenix, Arizona, United States
Total Funding:
1382086
Founded Date:
2015-04-02
Employee Number:
1-10
Last Funding Type:
Grant
Investors Number:
2
Last Funding Date:
2018-03-19
Technology:
['BioTech & HealthTech', 'Education, Research & SocialTech']
Estimated Revenue:
$1M to $10M
Industry:
Aging Biomarkers